Protalix Biotherapeutics
Price & Volume
Stats
See more52W Range | $0.82-$2.54 |
Market Cap | $178.9M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $38M |
Revenue Growth (YoY) | -61.6% |
Gross Profit (12 Mos) | $12.2M |
Diluted EPS | -$0.15 |
News
See moreYahoo Finance • last year
Levicept Appoints Eliot Forster as CEO
Yahoo Finance • 2 years ago
Protalix BioTherapeutics Announces $20 Million Milestone Payment from Chiesi Global Rare Diseases
Yahoo Finance • 2 years ago
Protalix BioTherapeutics Reports First Quarter 2023 Financial and Business Results
About
CEO | Mr. Dror Bashan |
CFO | Mr. Eyal Rubin M.B.A. |
Address | Science Park, Karmiel, Israel, 2161401 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 208 |
